Alignment Healthcare, Inc.
ALHCNasdaqFinancials · Hospital & Medical Service Plans · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $3.95B | $2.70B | $1.80B | $1.43B | $1.17B | $955.4M |
| Operating income | $14.8M | −$101.6M | −$127.8M | −$128.6M | −$178.1M | −$5.3M |
| Net income | −$724,000 | −$128.0M | −$148.0M | −$149.5M | −$195.3M | −$22.9M |
| Total assets | $1.07B | $782.1M | $591.9M | $633.9M | $630.9M | $338.5M |
| Total liabilities | $886.5M | $681.1M | $433.8M | $394.6M | $324.8M | $307.9M |
| Equity | $179.3M | $99.9M | $156.9M | $238.1M | $306.0M | $30.6M |
| EPS (diluted) | $0.00 | $-0.67 | $-0.79 | $-0.83 | $-1.14 | $-0.15 |
| Shares out. | 191.8M | 189.0M | 187.3M | 187.1M | 187.2M | 164.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 0.4%
- Net margin
- −0.0%
- Return on equity
- −0.4%
- Return on assets
- −0.1%
- Return on capital (ROCE)
- 2.9%
- Liabilities / assets
- 83.2%
- Debt / equity
- 4.94×
- Book value / share
- $0.93
- Revenue growth (YoY)
- 46.1%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -0.35distress
- Accruals / assets
- −13.2%clean
- Piotroski F-Score
- 6/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 2 warning● 4 good- Altman Z″ in the distress zone
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Operating margin is positive
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- General Atlantic, L.P.Passive (13G)May 15, 2026
- Wellington Management Group LlpPassive (13G)May 15, 2026
- Blackrock, Inc.Passive (13G)Apr 24, 2026
- Vanguard Group IncPassive (13G)Mar 26, 2026
- Fmr LlcPassive (13G)Feb 5, 2026
- Citadel Advisors LlcPassive (13G)Nov 14, 2025
- Qatar Investment AuthorityPassive (13G)Sep 24, 2025
- T. Rowe Price Investment Management, Inc.Passive (13G)Aug 14, 2025
- Warburg Pincus Private Equity Xii, L.P.Passive (13G)Feb 14, 2025
- Flynn James EPassive (13G)Feb 13, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Maroney Dawn ChristineOfficer — President | May 15, 2026 | Sell | 30,000 | $16.09 |
| Kao John EOfficer — Chief Executive Officer | May 11, 2026 | Sell | 280,893 | $16.85 |
| Maroney Dawn ChristineOfficer — President | Apr 15, 2026 | Sell | 30,000 | $20.87 |
| Kao John EOfficer — Chief Executive Officer | Apr 10, 2026 | Sell | 201,900 | $20.58 |
| Head James MOfficer — Chief Financial Officer | Apr 7, 2026 | Sell | 11,100 | $21.08 |
| Kao John EOfficer — Chief Executive Officer | Apr 7, 2026 | Sell | 132,241 | $20.67 |
| Joyce Christopher JOfficer — Chief Legal and Admin. Officer | Apr 1, 2026 | Sell | 18,013 | $17.79 |
| Kao John EOfficer — Chief Executive Officer | Mar 23, 2026 | Sell | 118,000 | $17.48 |
| Burzacchi SebastianOfficer — COO - Mgmt Services Org | Mar 18, 2026 | Sell | 15,361 | $17.84 |
| Kim HyongOfficer — Chief Medical Officer | Mar 18, 2026 | Sell | 18,404 | $17.84 |
| Joyce Christopher JOfficer — Chief Legal and Admin. Officer | Mar 18, 2026 | Sell | 25,125 | $17.84 |
| Maroney Dawn ChristineOfficer — President | Mar 18, 2026 | Sell | 36,749 | $17.84 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 25.1M | 2.7 | +55.6% |
| Apr 30, 2026 | 16.1M | 4.9 | -4.9% |
| Apr 15, 2026 | 17.0M | 4.5 | +3.5% |
| Mar 31, 2026 | 16.4M | 5.4 | +3.0% |
| Mar 13, 2026 | 15.9M | 4.6 | -0.1% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Amended charter or bylaws · Regulation FD disclosureMay 12, 2026
- Results of operationsApr 30, 2026
- Entered a material agreementMar 4, 2026
- Results of operationsFeb 26, 2026
- Regulation FD disclosureJan 12, 2026
- Results of operationsOct 30, 2025
- Regulation FD disclosureSep 9, 2025
- Results of operationsJul 30, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 3FORM 3May 20, 2026
- 4FORM 4May 19, 2026
- SCHEDULE 13G/AMay 15, 2026
- SCHEDULE 13G/AMay 15, 2026
- 4FORM 4May 13, 2026
- DEFA14AMay 12, 2026
- 8-KMay 12, 2026
- 144May 11, 2026
- 10-QApr 30, 2026
- 8-KFORM 8-KApr 30, 2026
- SCHEDULE 13G/AApr 24, 2026
- ARSApr 24, 2026
- DEFA14AApr 24, 2026
- DEF 14AApr 24, 2026
- 4FORM 4Apr 15, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.